Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis
R Olsson, I Hägerstrand, U Broomé, A Danielsson, G Järnerot, L Lööf, H Prytz, B O Rydén, S Wallerstedt, R Olsson, I Hägerstrand, U Broomé, A Danielsson, G Järnerot, L Lööf, H Prytz, B O Rydén, S Wallerstedt
Abstract
Aims: To study sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis (PSC).
Methods: One hundred and twelve biopsy specimens (that is, 56 pairs) from 44 patients with PSC, confirmed by cholangiography, were evaluated blindly. Six different features, qualitative grading of four other features and staging according to Ludwig were assessed.
Results: Quantitative sampling variability was confined mainly to just one grade or stage, although 11% (six of 56) of the biopsy specimen pairs differed by more than one stage (7% (one of 15) in pairs > 2 cm in length). Qualitative sampling variabilities were between 18 and 71%. Advanced disease (stages 3 or 4) was missed in 40% (two of five) of the biopsy specimens while cirrhosis was missed in 37%.
Conclusion: Paired liver biopsy specimens should be taken in clinical studies of PSC using liver histology for evaluation or prognosis.
References
- Dtsch Med Wochenschr. 1969 Aug 15;94(33):1633-7
- Am J Dig Dis. 1971 Dec;16(12):1082-6
- Acta Pathol Microbiol Scand A. 1979 Jan;87(1):51-7
- Arch Intern Med. 1979 Jun;139(6):667-9
- Gut. 1980 Oct;21(10):870-7
- Arch Pathol (Chic). 1950 Sep;50(3):326-8
- J Clin Pathol. 1985 Jul;38(7):778-83
- Lancet. 1986 Mar 8;1(8480):523-5
- Am J Surg Pathol. 1989;13 Suppl 1:43-9
- Hepatology. 1992 Nov;16(5):1290-9
- Gastroenterology. 1995 Apr;108(4):1199-203
- Hepatology. 1981 Nov-Dec;1(6):632-40
Source: PubMed